United States
Choose your country or region:
France
Germany
Italy
Japan
United Kingdom
About
Leadership
Board of Directors
Company History
Corporate Impact and Community Relations
Our Collaborations
Contact Us
Newsroom
News & Stories
Press Releases
Multimedia
Our Tests
Cologuard®
OncoExTra™
Oncoguard® Liver
Oncotype DX®
Oncotype DX Breast DCIS Score®
Oncotype DX Breast Recurrence Score®
Oncotype DX Colon Recurrence Score®
Riskguard™
Pipeline & Data
Breast Radiation Score
Cologuard® 2.0
Colorectal Cancer Blood
LBgard® Blood Tubes
Molecular Residual Disease
Multi-Cancer Early Detection
Clinical Studies
Research
Publications & Abstracts
Exact Academy
Investor Relations
Press Releases
Events & Presentations
Corporate Governance
Stock Information
Financial Information
Email Alerts
Contact Us
Join Our Team
×
DIGITAL NEWSROOM
Posts by:
Exact Sciences
June 23, 2017
Jerry Kelly and Exact Sciences Team Up to Promote Colon Cancer Screening
April 28, 2017
Cologuard growth accelerates to $48.4 million in revenue during first quarter; volume grows 150 percent year over year to 100,000 completed tests
April 04, 2017
CMS includes Cologuard in updated Medicare Advantage Star Ratings
February 21, 2017
Exact Sciences generated $99.4 million in revenues during 2016, a 152-percent increase
February 02, 2017
CMS Proposes Inclusion of Cologuard in Medicare Advantage Star Ratings
January 08, 2017
Exact Sciences to report $99 million in revenues, 150 percent growth for 2016
January 05, 2017
Cologuard Earns Positive Review from Blue Cross Blue Shield Association
December 21, 2016
Exact Sciences Joins Deloitte’s Technology Fast 500 as One of the Sector’s Fastest Growing Companies
December 12, 2016
Cologuard Available to Humana Members as In-Network Colon Cancer Screening Option
November 08, 2016
Exact Sciences Appoints Jeff Elliott Chief Financial Officer
October 28, 2016
Exact Sciences' Cologuard Wins Prestigious Prix Galien Award for Best Medical Technology Product
October 26, 2016
Exact Sciences Completes 68,000 Cologuard Tests During the Third Quarter
...
5
6
7
8
9
10
11
12
13
...